Compare the Clinical Efficacy of 3% Diquafosol and 0.1% Hyaluronic Acid in Patients with Dry Eye After Trans-PRK

Not yet recruiting 76 enrolled He Eye Hospital

Non-randomizedParallel-groupSingle-blindOther

Summary

The prevalence of refractive ametropia is rising year by year. Refractive surgery has become the main approach for adults to correct refractive ametropia, and postoperative complications have aroused extensive attention from clinicians. Dry eye after refractive surgery is one of the postoperative complications, which is an important cause of affecting the postoperative visual quality and satisfaction of patients. It was reported that 3% diquafosol (DQS) and 0.1% hyaluronic acid (HA) can relieve dry eye symptoms. This study aims to compare the efficacy of 3% DQS and 0.1% HA in treating dry eye after Trans-PRK

Timeline

Start: 2025-02-28
Primary completion: 2026-05-28
Completion: 2026-05-31

Publications

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Diquafosol	Oligonucleotide (other)	3 %	Other
Subject	Hyaluronic Acid	Other / unclassified	0.1 %	Other

Compare the Clinical Efficacy of 3% Diquafosol and 0.1% Hyaluronic Acid in Patients with Dry Eye After Trans-PRK

Summary

Timeline

Publications

Drugs

Indications